Infectious Diseases

How mRNA vaccines work and how healthcare professionals can help fight lingering vaccine hesitancy
Almost 30% of Canadians age 12 and older have not received their two doses. To address lingering vaccine hesitancy, we spoke with community pharmacist John Papastergiou and primary care physician Peter Lin about mRNA vaccines.
Sponsored
Cross-country snapshot of unvaccinated Canadian healthcare workers
Many are not immune to COVID-19 conspiracy theories and misinformation.

Pfizer COVID-19 vaccine unlikely to cause relapse of Guillain-Barré syndrome

Study suggests minimal risk of relapse when Pfizer-BioNTech mRNA COVID-19 vaccine is given to patients with a history of GBS.
Ivermectin: efficacy and safety data lacking for COVID-19 prevention or treatment

Health Canada advises consumers not use veterinary or human dosage forms of ivermectin to prevent or treat COVID-19.
Vaccine hesitancy highest in Alberta, racialized groups at rollout's start: survey

The survey, led by researchers at Toronto's St. Michael's Hospital, was published online Tuesday in The Lancet Regional Health–Americas.
One jab has almost no effect against Delta: study

According to a recently published study, two shots are better than one when it comes to protection against the SARS-CoV-2 Delta, as well as other, variants of the virus.
J&J: Potential HIV vaccine falls short in mid stage study

The study in sub-Saharan Africa involved about 2,600 women who were deemed to be at high risk of acquiring HIV, which causes AIDS.
Six things to tell patients about the Delta variant of SARS-CoV-2

Spreads faster than early forms of SARS-CoV-2 and is now the predominant variant in Canada and the United States
Ontario's Vaccine Clinical Advisory Group recommends some cohorts receive third mRNA vaccine

The update outlines the specific populations who would most benefit from a third or booster shot.
Health Canada considering new oral antiviral for treatment of COVID-19

Merck’s molnupiravir is a twice-daily oral antiviral agent currently under study as a potential treatment for mild/moderate COVID-19.

How mRNA vaccines work and how healthcare professionals can help fight lingering vaccine hesitancy

Cross-country snapshot of unvaccinated Canadian healthcare workers

Pfizer COVID-19 vaccine unlikely to cause relapse of Guillain-Barré syndrome

Ivermectin: efficacy and safety data lacking for COVID-19 prevention or treatment

Vaccine hesitancy highest in Alberta, racialized groups at rollout's start: survey

One jab has almost no effect against Delta: study

J&J: Potential HIV vaccine falls short in mid stage study

Six things to tell patients about the Delta variant of SARS-CoV-2

Ontario's Vaccine Clinical Advisory Group recommends some cohorts receive third mRNA vaccine

Health Canada considering new oral antiviral for treatment of COVID-19